A day after announcing that it would make an equity investment in next-generation DNA sequencing technology firm VisiGen Biotechnologies, Applied Biosystems officials said last week that it continues to evaluate other alternative sequencing technologies.

ABI also surprised the market with a relatively strong fiscal 2006 first-quarter, reporting a 6.4-percent increase in revenue and a 55-percent jump in profits.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The Washington Post reports on a Federal Bureau of Investigation plan to place rapid DNA analyzers at booking stations around the country.

In an editorial, officials from scientific societies in the US and China call for the international community to develop criteria and standards for human germline editing.

The US National Institutes of Health is to review studies that have received private support for conflicts of interest, according to the New York Times.

In Science this week: the PsychENCODE Consortium reports on the molecular mechanisms of neuropsychiatric disorders, and more.